For USA

Product Strength Therapeutic Area Status
Glimepiride Tablets 1/2 mg Antidiabetics ANDA Approved
Simvastatin Tablets 10/20/40/80 mg Hypertension ANDA Approved
Pravastatin Sodium Tablets 10/20/40/80 mg Cardiovascular ANDA under Approval
Mycophenolate Mofetil Tablets 500 mg Immune System-Immunosuppression ANDA Approved
Bicalutamide Tablets 50 mg Oncology/Hematology ANDA under Approval
Finasteride Tablets 5 mg Benign Prostatic Hyperplacia ANDA under Approval
Irinotican HCL Injection 20 mg/ml, 2 ml, 5 ml Oncology/Hematology ANDA under Approval
Anastrazole Tablets 1 mg Oncology/Hematology ANDA Filed
Etoposide Injection 20 mg/ml - 12.5/25 ml Oncology/Hematology Filing planned in QII 08
Gemcitabine Injection 200/1000 mg Oncology/Hematology Filing planned in QI 08
Letrozole Tablets 2.5 mg Oncology/Hematology Filing planned in QI 08
Levetiracetam Tablets 250/500/750/1000 mg Neurology ANDA Filed
Meloxicam Injection - Veternary 5 mg/ml, 10 ml Analgecia-Inflammation ANDA Filed
Mitomycin Injection 5 mg, 20 mg Oncology/Hematology ANDA Filed
Mycophenolate Mofetil Capsules 250 mg Immune System-Immunosuppression ANDA Filed
Paclitaxel Injection 6 mg/ml - 5/16.7/50 ml Oncology/Hematology Filing planned in QI 08
Paclitaxel Injection 6 mg/ ml - 5/ 16.7/ 50 ml Oncology/Hematology ANDA Filed
Back
 
 
 
Corporate Profile | Group Companies  | Global Impressions  | Product Info. & Reg.  | Report Complaints/Adverse Events  | Contact Us